Proenkephalin (penKid) Sheds Light on the Diagnostic Blind Spots in Assessing Acute Kidney Injury in Children newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Frontiers | Integrated Care in the Era of COVID-19: Turning Vision Into Reality With Digital Health frontiersin.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frontiersin.org Daily Mail and Mail on Sunday newspapers.
HemoSonics welcomes the January 14th guidance of the US Food and Drug Administration that broadens the use of viscoelastic coagulation analyzers for hospital patient healthcare settings in response.
DGAP-News: Proen .
DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
vom 16.12.2020, 10:00 Uhr
Bild: pixabay.com
DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement
Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients
16.12.2020 / 10:00
The issuer is solely responsible for the content of this announcement.
The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI)
The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice